KR100663785B1 - 캐피어 그레인으로부터 분리된 신균주 - Google Patents
캐피어 그레인으로부터 분리된 신균주 Download PDFInfo
- Publication number
- KR100663785B1 KR100663785B1 KR1020050006290A KR20050006290A KR100663785B1 KR 100663785 B1 KR100663785 B1 KR 100663785B1 KR 1020050006290 A KR1020050006290 A KR 1020050006290A KR 20050006290 A KR20050006290 A KR 20050006290A KR 100663785 B1 KR100663785 B1 KR 100663785B1
- Authority
- KR
- South Korea
- Prior art keywords
- caper
- lactic acid
- acid bacteria
- powder
- grains
- Prior art date
Links
- 235000015141 kefir Nutrition 0.000 title abstract description 6
- 244000005700 microbiome Species 0.000 title 1
- 235000017336 Capparis spinosa Nutrition 0.000 claims abstract description 34
- 150000004676 glycans Chemical class 0.000 claims abstract description 23
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 23
- 239000005017 polysaccharide Substances 0.000 claims abstract description 23
- 241000722721 Capparis Species 0.000 claims description 27
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 40
- 241000894006 Bacteria Species 0.000 abstract description 27
- 239000004310 lactic acid Substances 0.000 abstract description 20
- 235000014655 lactic acid Nutrition 0.000 abstract description 20
- 238000004519 manufacturing process Methods 0.000 abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 10
- 244000140995 Capparis spinosa Species 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 3
- 241000873224 Capparaceae Species 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 239000000843 powder Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 16
- 238000011534 incubation Methods 0.000 description 9
- 241000186660 Lactobacillus Species 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 235000020183 skimmed milk Nutrition 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 241001468191 Lactobacillus kefiri Species 0.000 description 5
- 235000013618 yogurt Nutrition 0.000 description 5
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 241000186610 Lactobacillus sp. Species 0.000 description 3
- 241001627205 Leuconostoc sp. Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006872 mrs medium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-URHLDCCQSA-N (2R,3S,4R,5S)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-URHLDCCQSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N Arbutin Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UHFFFAOYSA-N D-Cellobiose Natural products OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229920001755 Kefiran Polymers 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000009160 phytotherapy Methods 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Test | Leuconostoc mesenteroides (KCTC 10724BP) | Lactobacillus kefiri (KCTC 10725BP) |
Glycerol | - | - |
Erythrotol | - | - |
D-Arabinose | - | - |
L-Arabinose | + | + |
D-Ribose | + | + |
D-Xylose | + | - |
L-Xylose | - | - |
D-Adonitol | - | - |
Methyl-β-D-Xylopyranoside | - | - |
D-Galactose | + | + |
D-Glucose | + | + |
D-Fructose | + | + |
D-Mannose | + | - |
L-sorbose | - | - |
L-Rhamnose | - | - |
Dulcitiol | - | - |
Inositol | - | - |
D-Mannitol | - | - |
D-Sorbitol | - | - |
Methyl-α-D-Mannopyranose | - | - |
Methyl-α-D-Glucopyranose | + | - |
N-Acetylglucosamine | + | - |
Amygdalin | - | - |
Arbutin | - | - |
Esculin ferric citrate | + | + |
Salicin | - | - |
D-Cellobiose | - | - |
D-Maltose | + | + |
D-Lactose | + | + |
D-Melibiose | + | + |
D-Saccharide(Sucrose) | + | - |
D-Trehalose | + | - |
Inulin | - | - |
D-Melezitose | - | - |
D-Raffinose | + | - |
Starch | - | - |
Glycogen | - | - |
Xylitol | - | - |
Gentiobiose | - | - |
D-Turanose | + | - |
D-Lyxose | - | - |
D-Tagatose | - | - |
D-Fucose | - | - |
L-Fucose | - | - |
D-Arabitol | - | - |
L-Arabitol | - | - |
Potassium gluconate | - | - |
Potassium-2-ketogluconate | - | - |
Potassium-5-ketogluconate | - | - |
배양온도 (℃) | 유산균 생균수(cfu/g) | 효모 생균수(cfu/g) | 다당 (mg/g) | ||||
제조시 | 3개월후 | 6개월후 | 제조시 | 3개월후 | 6개월후 | ||
15 | 5.0×104 | 4.8×104 | 3.5×104 | 2.0×102 | 2.0×102 | 1.8×102 | 12 |
20 | 4.2×109 | 4.5×109 | 4.0×109 | 2.0×104 | 2.0×104 | 1.7×104 | 22 |
25 | 3.0×1010 | 2.9×1010 | 2.7×1010 | 4.0×105 | 3.7×105 | 3.6×105 | 32 |
30 | 2.5×1010 | 2.0×1010 | 2.0×1010 | 5.0×105 | 4.5×105 | 4.4×105 | 27 |
35 | 1.5×107 | 1.5×107 | 1.4×107 | 4.0×104 | 3.7×104 | 3.6×104 | 25 |
배양시간 (h) | 유산균 생균수(cfu/g) | 효모 생균수(cfu/g) | 다당 (mg/g) | ||||
제조시 | 3개월후 | 6개월후 | 제조시 | 3개월후 | 6개월후 | ||
6 | 5.0×104 | 4.8×104 | 4.2×104 | 2.0×102 | 2.0×102 | 1.8×102 | 0 |
9 | 4.0×107 | 3.8×107 | 3.8×107 | 4.0×103 | 3.2×103 | 3.6×103 | 0 |
15 | 1.2×1010 | 1.0×1010 | 1.0×1010 | 4.0×104 | 3.7×104 | 3.7×104 | 11 |
20 | 3.5×1010 | 3.5×1010 | 3.0×1010 | 5.0×105 | 4.7×105 | 4.1×105 | 32 |
24 | 2.0×1010 | 1.9×1010 | 1.8×1010 | 4.8×105 | 4.7×105 | 3.9×105 | 25 |
30 | 3.8×109 | 3.5×109 | 3.6×109 | 4.9×105 | 4.4×105 | 4.2×105 | 24 |
첨가량 (wt/vol) | 유산균 생균수(cfu/g) | 효모 생균수(cfu/g) | 다당 (mg/g) | ||||
제조시 | 3개월후 | 6개월후 | 제조시 | 3개월후 | 6개월후 | ||
0 | 3.5×1010 | 3.5×1010 | 3.0×1010 | 4.0×105 | 4.0×104 | 4.0×105 | 32 |
5 | 4.4×1010 | 4.2×1010 | 4.3×1010 | 4.5×105 | 3.9×105 | 3.9×105 | 38 |
10 | 3.3×1010 | 2.9×1010 | 2.7×1010 | 2.3×105 | 2.2×105 | 2.1×105 | 40 |
15 | 2.5×1010 | 2.4×1010 | 2.0×1010 | 1.3×105 | 1.1×105 | 1.0×105 | 35 |
Claims (2)
- 캐피어 그레인으로부터 분리한, 다당 생성능이 우수한 신균주 류코노스톡 메센테로이드(Leuconostoc mesenteroides) E-1(KCTC 10724BP)
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050006290A KR100663785B1 (ko) | 2005-01-24 | 2005-01-24 | 캐피어 그레인으로부터 분리된 신균주 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050006290A KR100663785B1 (ko) | 2005-01-24 | 2005-01-24 | 캐피어 그레인으로부터 분리된 신균주 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060085429A KR20060085429A (ko) | 2006-07-27 |
KR100663785B1 true KR100663785B1 (ko) | 2007-01-02 |
Family
ID=37175136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050006290A KR100663785B1 (ko) | 2005-01-24 | 2005-01-24 | 캐피어 그레인으로부터 분리된 신균주 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100663785B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102427965B1 (ko) * | 2019-01-30 | 2022-08-02 | 주식회사 장수퍼맨텍 | 복합 유산균 발효 식품 개발을 위한 복합 유산균 선발 방법 |
-
2005
- 2005-01-24 KR KR1020050006290A patent/KR100663785B1/ko active IP Right Grant
Non-Patent Citations (1)
Title |
---|
논문 * |
Also Published As
Publication number | Publication date |
---|---|
KR20060085429A (ko) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9788557B2 (en) | Lactobacillus classified as Lactobacillus plantarum, and use thereof | |
KR100911115B1 (ko) | 내산성, 내담즙산성 및 항균 효과를 가진 신규한 유산균 및 이를 포함하는 조성물 | |
CN109536415A (zh) | 一种鼠李糖乳杆菌及其应用 | |
EP2540816B1 (en) | Method for constructing novel bacterium belonging to the genus bifidobacterium | |
US20110123640A1 (en) | Novel fermented milk product and use thereof | |
CN107208040B (zh) | 乳酸菌、来源于该乳酸菌的天然免疫活化剂、感染症预防治疗剂和饮食品 | |
US11801276B2 (en) | Microorganism having ability to degrade ethanol and acetaldehyde, and composition and kit each including the same | |
KR101700625B1 (ko) | 페디오코커스 펜토사세우스 kcc-23 및 이를 포함하는 조성물 | |
CN109890954B (zh) | 具有透明质酸产生促进能力的乳酸菌 | |
US20090022850A1 (en) | Acid tolerant leuconostoc mesenteroides with excellent mannitol productivity and method for producing a kimchi using the same | |
EP3124599A1 (en) | Lactic acid bacterium belonging to genus weissella | |
KR102269477B1 (ko) | 신규한 바실러스 벨레젠시스 wk2019 균주 및 이를 이용한 우유발효물 제조방법 | |
KR100663785B1 (ko) | 캐피어 그레인으로부터 분리된 신균주 | |
EP2154238B1 (en) | Novel lactic acid bacterium strain, fermented food/beverage, and method for production of fermented food/beverage | |
JP3875237B2 (ja) | ビフィドバクテリウム・ロンガム | |
Zhang et al. | Isolation and identification of dominant microorganisms involved in naturally fermented goat milk in Haixi region of Qinghai, China | |
KR101809447B1 (ko) | 류코노스톡 메센테로이드 drc1506 균주 및 이의 용도 | |
US20160115559A1 (en) | Bacterium belonging to genus lactobacillus | |
KR101880650B1 (ko) | 에탄올 및 아세트알데히드 분해능을 가진 미생물, 그를 포함하는 조성물 및 키트 | |
KR102633113B1 (ko) | 기능성 발효음료에 적합한 락토바실러스 브레비스 lrcc5229 균주 및 이의 용도 | |
KR20150088588A (ko) | 신규한 감마아미노부티르산 고생산성 균주 락토바실러스 브레비스 cfm11 및 이의 용도 | |
KR101971186B1 (ko) | 비피도박테리움 애니멀리스 서브스페시스 락티스 HY8002와 비피도박테리움 아돌레센티스 HY8502의 유산균 조합을 이용한 진세노사이드 Rd가 강화된 발효홍삼 농축액의 제조방법 | |
Das | Starter culture development of Sindol-a fermented fish product of Assam. | |
KR20230038477A (ko) | 유산균 및 그 취득 방법과 유산균 함유 음식품 | |
JP2022117889A (ja) | 酸化ストレス抵抗性付与能(il-8抑制能)及び小腸幹細胞遺伝子調節機能を有する乳酸菌 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121204 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131105 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141217 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151202 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161202 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171204 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20191115 Year of fee payment: 14 |